Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clinical Investigation of a Novel Spectacle Lens on Slowing Down Juvenile Myopia Progression
Sponsor: Essilor International
Summary
The goal of this exploratory clinical trial is to evaluate the efficacy and safety of a test spectacle lens (standard single vision lens (SVL) during first year, and standard myopia control lens (MCL) in second year), designed with passive red-light emission, for the control of myopia progression in myopic children age 6 to 11 years old, both male and female, with no systemic or ocular anomalies. The main question it aims to answer is: Does the test spectacle lens designed with passive red-light emission provide significant myopia control effect to children? Researchers will compare the standard SVL designed with passive red-light emission to SVL (first year) and MCL designed with passive red-light emission to MCL (second year) to see if the test spectacle lens work to slow down myopia progression. Participants will: * Wear the study spectacles * Visit Essilor R\&D Centre for follow-up sessions
Key Details
Gender
All
Age Range
6 Years - 11 Years
Study Type
INTERVENTIONAL
Enrollment
35
Start Date
2025-06-26
Completion Date
2027-12
Last Updated
2025-08-07
Healthy Volunteers
No
Conditions
Interventions
SVL
Dispensed to one eye in Year 1
SVL with passive red-light emission
Dispensed to the contralateral eye in Year 1.
MCL
Dispensed to one eye in Year 2 (if used SVL with passive red-light emission in Year 1).
MCL with passive red-light emission
Dispensed to the contralateral eye in Year 2 (if used SVL in Year 1).
Locations (1)
Essilor R&D Centre Singapore
Singapore, Singapore